ReviewFrontiers in endocrinology2022

Target Therapy in Thyroid Cancer: Current Challenge in Clinical Use of Tyrosine Kinase Inhibitors and Management of Side Effects.

Ivana Puliafito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.